Shared Decision‐Making in Treatment Selection in Multiple Myeloma in Spain: The <scp>PRISMMA</scp> Study

While general agreement between patients and haematologists on extending survival with good quality of life was found for the main treatment goal, a need to align second treatment goals and improve the shared decision-making was identified. Addressing these differences is important to ensure the selection of the most appropriate treatment for the individual patient at each stage of their journey.